Antenatal Care (ANC)
Published on May 16, 2026
Domain | Detail |
|---|---|
Definition | Integrated antenatal care (ANC Terpadu) encompassing all activities from conception until the onset of labor, aimed at ensuring a healthy pregnancy and a positive birth experience |
Target Population | All pregnant women, with heightened surveillance for those with risk factors (age ≤16 or ≥35, grand multiparity ≥4, prior cesarean section, prior obstetric complications, multiple gestation, chronic disease) |
Visit Schedule | Minimum 6 contacts (K6): 1x in trimester 1 (0-12 weeks), 2x in trimester 2 (>12-24 weeks), 3x in trimester 3 (>24 weeks to delivery). At least 2 visits must be with a physician (1x in T1 and 1x in T3) |
Standard of Care | 10T (10 standardized service components performed at each antenatal visit) |
Key Screening | Triple elimination screening (HIV, Syphilis, Hepatitis B) via rapid tests at the first trimester 1 visit; hemoglobin, blood type and Rh; malaria (endemic areas); urinalysis and blood glucose as indicated |
Supplementation | Iron-folate tablets (Tablet Tambah Darah/TTD), minimum 90 tablets throughout pregnancy |
Immunization | Tetanus-Diphtheria (Td) vaccine, targeting T5 status for lifelong protection |
Counseling | Results of examination, age-appropriate care, nutrition, birth preparedness, recognition of danger signs, postpartum contraception planning, exclusive breastfeeding, early initiation of breastfeeding (IMD), and mental health assessment |
Keywords for Exam Vignettes | "K1," "K4," "K6," "10T," "ANC terpadu," "triple eliminasi," "Tablet Tambah Darah 90 tablet," "LILA <23.5 cm = KEK," "Td immunization status T1-T5," "USG trimester 1 and trimester 3" |
01Overview and Rationale
Antenatal care exists to detect, prevent, and manage conditions that threaten the mother and fetus before labor begins. The Kemenkes 2021 regulation shifted the minimum visit standard from 4 contacts (K4) to 6 contacts (K6), aligning with the 2016 WHO recommendation that emphasizes more frequent contact to improve detection of complications and to provide a positive pregnancy experience.
The concept of ANC Terpadu (integrated ANC) is central. This is not simply an obstetric check-up; it is a platform that integrates screening and management for nutritional deficiencies, communicable diseases (HIV, syphilis, hepatitis B, malaria, tuberculosis), non-communicable diseases (hypertension, diabetes, heart disease), and mental health disorders (depression, anxiety, psychosis). Test-writers frequently assess whether students understand that ANC is a comprehensive screening opportunity, not just a fundal height measurement.
A critical exam concept is the distinction between K1 (access indicator, first contact ideally before week 8), K4 (quality indicator under the old standard, 4 visits minimum), and K6 (current quality indicator, 6 visits minimum). The visit distribution for K6 is: 1x trimester 1, 2x trimester 2, 3x trimester 3. The requirement for 2 physician visits (trimester 1 and trimester 3), each including ultrasonography (USG), is a high-yield testable point.
02Visit Schedule and Distribution
K4 (old standard)
Minimum Visits
4
Trimester 1 (0-12 wk)
1x
Trimester 2 (>12-24 wk)
1x
Trimester 3 (>24 wk to delivery)
2x
K6 (current standard, Permenkes 21/2021)
Minimum Visits
6
Trimester 1 (0-12 wk)
1x
Trimester 2 (>12-24 wk)
2x
Trimester 3 (>24 wk to delivery)
3x
Physician contact
Minimum Visits
2 (mandatory)
Trimester 1 (0-12 wk)
1x (screening + USG)
Trimester 2 (>12-24 wk)
--
Trimester 3 (>24 wk to delivery)
1x (birth planning + USG)
Indicator | Minimum Visits | Trimester 1 (0-12 wk) | Trimester 2 (>12-24 wk) | Trimester 3 (>24 wk to delivery) |
|---|---|---|---|---|
K4 (old standard) | 4 | 1x | 1x | 2x |
K6 (current standard, Permenkes 21/2021) | 6 | 1x | 2x | 3x |
Physician contact | 2 (mandatory) | 1x (screening + USG) | -- | 1x (birth planning + USG) |
First visit (K1) should occur as early as possible in trimester 1, ideally before 8 weeks of gestation. At this visit, the physician performs a comprehensive risk factor screening and the first USG. The trimester 3 physician visit focuses on delivery planning, fetal presentation assessment, repeat USG, and arranging a planned referral if needed.
Additional visits beyond 6 are warranted whenever there are complaints, detected disease, or pregnancy complications.
03The 10T Standard (Standar Pelayanan Antenatal)
This is the backbone of every ANC visit and the most commonly tested framework.
T1
Component (Indonesian shorthand)
Timbang berat badan dan ukur tinggi badan
What Is Done
Weigh the patient, measure height (first visit only for height)
Key Exam Detail
Height is measured once; weight is tracked at every visit to monitor appropriate gestational weight gain
T2
Component (Indonesian shorthand)
Ukur tekanan darah
What Is Done
Blood pressure measurement
Key Exam Detail
Screening for hypertensive disorders; systolic ≥140 or diastolic ≥90 mmHg triggers workup for preeclampsia
T3
Component (Indonesian shorthand)
Nilai status gizi (ukur LILA)
What Is Done
Mid-upper arm circumference (MUAC/LILA) measurement
Key Exam Detail
LILA <23.5 cm = Chronic Energy Deficiency (KEK); risk of low birth weight (BBLR)
T4
Component (Indonesian shorthand)
Ukur tinggi puncak rahim (fundus uteri)
What Is Done
Symphysis-fundal height measurement
Key Exam Detail
Screens for fetal growth restriction or macrosomia; discrepancy with gestational age requires USG
T5
Component (Indonesian shorthand)
Tentukan presentasi janin dan DJJ
What Is Done
Determine fetal presentation and fetal heart rate (DJJ)
Key Exam Detail
Fetal heart rate normal 120-160 bpm; presentation assessment relevant from third trimester onward
T6
Component (Indonesian shorthand)
Skrining status imunisasi tetanus, berikan Td bila diperlukan
What Is Done
Tetanus-Diphtheria immunization screening and administration
Key Exam Detail
Target is T5 status (lifelong protection >25 years); if unknown status, restart from T1
T7
Component (Indonesian shorthand)
Pemberian Tablet Tambah Darah (TTD)
What Is Done
Iron-folate supplementation
Key Exam Detail
Minimum 90 tablets over the entire pregnancy, given as 1 tablet daily starting as early as possible, continued through the postpartum period
T8
Component (Indonesian shorthand)
Tes laboratorium
What Is Done
Laboratory investigations
Key Exam Detail
Routine: pregnancy test, Hb, blood type + Rh, triple elimination (HIV, syphilis, HBsAg). Endemic areas: malaria rapid test. As indicated: urine glucose-protein, random blood glucose, sputum AFB, complete blood count for thalassemia screening
T9
Component (Indonesian shorthand)
Tata laksana / penanganan kasus
What Is Done
Case management per competency
Key Exam Detail
Management or referral of any detected complication
T10
Component (Indonesian shorthand)
Temu wicara (konseling) dan penilaian kesehatan jiwa
What Is Done
Counseling and mental health assessment
Key Exam Detail
Covers exam results, nutrition, birth preparedness, danger sign recognition, postpartum contraception, breastfeeding, and mental health screening (minimum at T1 and T3)
No. | Component (Indonesian shorthand) | What Is Done | Key Exam Detail |
|---|---|---|---|
T1 | Timbang berat badan dan ukur tinggi badan | Weigh the patient, measure height (first visit only for height) | Height is measured once; weight is tracked at every visit to monitor appropriate gestational weight gain |
T2 | Ukur tekanan darah | Blood pressure measurement | Screening for hypertensive disorders; systolic ≥140 or diastolic ≥90 mmHg triggers workup for preeclampsia |
T3 | Nilai status gizi (ukur LILA) | Mid-upper arm circumference (MUAC/LILA) measurement | LILA <23.5 cm = Chronic Energy Deficiency (KEK); risk of low birth weight (BBLR) |
T4 | Ukur tinggi puncak rahim (fundus uteri) | Symphysis-fundal height measurement | Screens for fetal growth restriction or macrosomia; discrepancy with gestational age requires USG |
T5 | Tentukan presentasi janin dan DJJ | Determine fetal presentation and fetal heart rate (DJJ) | Fetal heart rate normal 120-160 bpm; presentation assessment relevant from third trimester onward |
T6 | Skrining status imunisasi tetanus, berikan Td bila diperlukan | Tetanus-Diphtheria immunization screening and administration | Target is T5 status (lifelong protection >25 years); if unknown status, restart from T1 |
T7 | Pemberian Tablet Tambah Darah (TTD) | Iron-folate supplementation | Minimum 90 tablets over the entire pregnancy, given as 1 tablet daily starting as early as possible, continued through the postpartum period |
T8 | Tes laboratorium | Laboratory investigations | Routine: pregnancy test, Hb, blood type + Rh, triple elimination (HIV, syphilis, HBsAg). Endemic areas: malaria rapid test. As indicated: urine glucose-protein, random blood glucose, sputum AFB, complete blood count for thalassemia screening |
T9 | Tata laksana / penanganan kasus | Case management per competency | Management or referral of any detected complication |
T10 | Temu wicara (konseling) dan penilaian kesehatan jiwa | Counseling and mental health assessment | Covers exam results, nutrition, birth preparedness, danger sign recognition, postpartum contraception, breastfeeding, and mental health screening (minimum at T1 and T3) |
04Laboratory Workup at ANC
Hemoglobin
Timing
First visit + repeat as indicated
Purpose
Detect anemia; Hb <11 g/dL in pregnancy = anemia
Exam Pearl
Low Hb in trimester 2 can be physiological (hemodilution); confirm with repeat and iron supplementation response
Blood type + Rh
Timing
First visit
Purpose
Identify Rh-negative mothers at risk for hemolytic disease of the newborn
Exam Pearl
If Rh-negative, anti-D immunoglobulin is the management principle
Triple elimination (HIV, Syphilis, HBsAg)
Timing
First visit, trimester 1 (rapid tests)
Purpose
Prevent mother-to-child transmission (PPIA program)
Exam Pearl
All three are done simultaneously as a package at K1; this is a national program mandate
Malaria RDT / microscopy
Timing
First visit (K1) in high-endemic areas; selective in low-endemic areas
Purpose
Detect malaria in pregnancy
Exam Pearl
In high-endemic areas: all pregnant women screened + given insecticide-treated bed nets
Urine glucose-protein
Timing
As indicated
Purpose
Screen for gestational diabetes and preeclampsia
Exam Pearl
Proteinuria in the setting of hypertension supports preeclampsia
Random blood glucose
Timing
As indicated
Purpose
Classify hyperglycemia as pre-existing DM type 2 or gestational DM
Exam Pearl
The regulation distinguishes between DM with pregnancy and gestational DM
Complete blood count (MCV, MCH, MCHC, RDW)
Timing
As indicated
Purpose
Thalassemia carrier screening
Exam Pearl
If mother is carrier, screen the father; if both are carriers, offer genetic counseling and consider prenatal diagnosis
Sputum AFB
Timing
If symptomatic
Purpose
TBC screening
Exam Pearl
All pregnant women are screened by history; if suspected, proceed with sputum and HIV test
Test | Timing | Purpose | Exam Pearl |
|---|---|---|---|
Hemoglobin | First visit + repeat as indicated | Detect anemia; Hb <11 g/dL in pregnancy = anemia | Low Hb in trimester 2 can be physiological (hemodilution); confirm with repeat and iron supplementation response |
Blood type + Rh | First visit | Identify Rh-negative mothers at risk for hemolytic disease of the newborn | If Rh-negative, anti-D immunoglobulin is the management principle |
Triple elimination (HIV, Syphilis, HBsAg) | First visit, trimester 1 (rapid tests) | Prevent mother-to-child transmission (PPIA program) | All three are done simultaneously as a package at K1; this is a national program mandate |
Malaria RDT / microscopy | First visit (K1) in high-endemic areas; selective in low-endemic areas | Detect malaria in pregnancy | In high-endemic areas: all pregnant women screened + given insecticide-treated bed nets |
Urine glucose-protein | As indicated | Screen for gestational diabetes and preeclampsia | Proteinuria in the setting of hypertension supports preeclampsia |
Random blood glucose | As indicated | Classify hyperglycemia as pre-existing DM type 2 or gestational DM | The regulation distinguishes between DM with pregnancy and gestational DM |
Complete blood count (MCV, MCH, MCHC, RDW) | As indicated | Thalassemia carrier screening | If mother is carrier, screen the father; if both are carriers, offer genetic counseling and consider prenatal diagnosis |
Sputum AFB | If symptomatic | TBC screening | All pregnant women are screened by history; if suspected, proceed with sputum and HIV test |
The test-writer logic here is: triple elimination at K1 is mandatory, not optional. The most commonly tested concept is the timing (trimester 1, first contact) and the fact that all three (HIV, syphilis, hepatitis B) are done as a single package using rapid tests that do not require specialized laboratory personnel.
05Supplementation, Immunization, and Nutrition
Iron-Folate Supplementation (TTD)
The standard is 1 tablet daily, minimum 90 tablets throughout pregnancy, started as early as possible and continued through the postpartum period. TTD addresses the physiological decline in hemoglobin that occurs due to plasma volume expansion during pregnancy, with the nadir in trimester 2 and partial recovery in trimester 3.
Contraindication: TTD is not given to women who already have an Hb ≥13 g/dL (per the regulation's guidance for non-pregnant females; during pregnancy, the threshold is adjusted clinically).
Tetanus-Diphtheria (Td) Immunization
The goal is T5 status for lifelong protection (>25 years). The immunization history is traced back from infancy:
T1
Interval
--
Duration of Protection
None
T2
Interval
4 weeks after T1
Duration of Protection
3 years
T3
Interval
6 months after T2
Duration of Protection
5 years
T4
Interval
1 year after T3
Duration of Protection
10 years
T5
Interval
1 year after T4
Duration of Protection
>25 years (effectively lifelong)
Status | Interval | Duration of Protection |
|---|---|---|
T1 | -- | None |
T2 | 4 weeks after T1 | 3 years |
T3 | 6 months after T2 | 5 years |
T4 | 1 year after T3 | 10 years |
T5 | 1 year after T4 | >25 years (effectively lifelong) |
A key exam trap: a child who completed the full infant immunization series (DPT-HB-Hib 1, 2, 3) is at T2 status, not T3. Completion of the 18-month booster brings them to T3. Completion of the school-age BIAS program (DT and Td) brings them to T5. If immunization status is unknown, restart from T1.
Nutritional Assessment
LILA <23.5 cm is the threshold for Chronic Energy Deficiency (KEK). This is a critical exam value. A woman with KEK who becomes pregnant has increased risk for anemia, hemorrhage at delivery, low birth weight, infection, miscarriage, stillbirth, and congenital malformations.
BMI classification used:
Category | BMI |
|---|---|
Severely underweight | <17.0 |
Underweight | 17.0 to <18.5 |
Normal | 18.5 to 25.0 |
Overweight | >25.0 to 27.0 |
Obese | >27.0 |
Women with KEK should ideally delay pregnancy until nutritional status is corrected.
06Integrated Programs Within ANC
The concept of ANC Terpadu means that multiple vertical programs are delivered through the ANC platform. This is high-yield because exam questions may present a pregnant woman at her first visit and ask which screenings must be performed.
Integrated Program | Key Action at ANC |
|---|---|
Nutrition | LILA measurement, TTD supplementation, KEK management |
Malaria Control | RDT/microscopy at K1 (endemic areas), insecticide-treated bed nets for all pregnant women in high-endemic areas, treatment of positive cases |
Tuberculosis | History-based screening for all; if suspected, sputum examination + HIV testing; treatment with OAT (Amikacin, Streptomycin, Ethionamide/Prothionamide are contraindicated in pregnancy) |
Triple Elimination (PPIA) | Rapid tests for HIV, syphilis, HBsAg at K1; positive results mandate treatment, facility-based delivery, breastfeeding counseling, and contraception counseling |
NCD (Hypertension, DM, Thalassemia) | Risk stratification for hypertension; classification of hyperglycemia (pre-existing vs. gestational DM); thalassemia carrier screening with CBC indices (MCV, MCH) |
Mental Health | Screening at minimum trimester 1 and trimester 3 using clinical interview; identifies stress, anxiety, depression, OCD, bipolar disorder, PTSD, psychosis, substance abuse |
07Risk Factors and Complications Encountered in ANC
Category | Examples |
|---|---|
Nutritional | Anemia, KEK (LILA <23.5 cm), obesity, inappropriate weight gain |
Obstetric Risk Factors | Age ≤16 or ≥35 years, youngest child ≤2 years old, first pregnancy after ≥4 years, interpregnancy interval >10 years, grand multiparity (≥4 deliveries), multiple gestation, malpresentation, macrosomia, poor obstetric history, prior cesarean section, post-term (>40 weeks) |
Obstetric Complications | Premature rupture of membranes, antepartum hemorrhage, preeclampsia/eclampsia, threatened preterm labor, dystocia, placenta previa |
Non-Communicable Disease | Hypertension, DM, cardiac disease, renal disease, asthma, cancer, epilepsy, autoimmune disease |
Communicable Disease | HIV, syphilis, hepatitis B, malaria, TB, dengue, typhoid |
Psychiatric | Depression, anxiety, psychosis, schizophrenia |
08Exam Context
Since ANC is a care protocol rather than a single diagnosis, the exam tests ANC through clinical scenario questions. Below are the most testable confusion points.
K4 vs. K6
Why Students Get Confused
Students recall the old 4-visit minimum
Key Discriminator
Current standard per Permenkes 21/2021 is K6 (minimum 6 visits). K4 is the legacy indicator.
TTD "90 tablets" vs. "1 tablet/week for adolescents"
Why Students Get Confused
Both involve iron-folate tablets
Key Discriminator
Adolescent (non-pregnant) girls receive 1 tablet per week year-round; pregnant women receive 1 tablet per day, minimum 90 tablets total
LILA 23.5 cm threshold for KEK
Why Students Get Confused
Confused with BMI cutoffs
Key Discriminator
LILA is used as a rapid field screening for chronic energy deficiency; BMI is used for overall nutritional status. LILA <23.5 cm = KEK is the high-yield number.
"Who must perform the ANC visit?"
Why Students Get Confused
Students assume all visits are by midwives (bidan)
Key Discriminator
Minimum 2 visits must be with a physician (trimester 1 and trimester 3), including USG at both
Triple elimination at K1
Why Students Get Confused
Students may only recall HIV testing and forget syphilis or hepatitis B
Key Discriminator
All three (HIV + syphilis + HBsAg) are tested simultaneously as a single package at the first contact
Td status "unknown"
Why Students Get Confused
Students assume partial protection
Key Discriminator
If immunization status cannot be verified (no KIA book, no records), the patient is treated as T1 and immunization restarts from the beginning
OAT in pregnancy
Why Students Get Confused
Students may not know which anti-TB drugs are contraindicated
Key Discriminator
Amikacin, Streptomycin, and Ethionamide/Prothionamide are not recommended during pregnancy
Mental health screening
Why Students Get Confused
Students overlook this as part of ANC
Key Discriminator
T10 explicitly includes mental health assessment, performed at minimum in trimester 1 and trimester 3
Exam Trap | Why Students Get Confused | Key Discriminator |
|---|---|---|
K4 vs. K6 | Students recall the old 4-visit minimum | Current standard per Permenkes 21/2021 is K6 (minimum 6 visits). K4 is the legacy indicator. |
TTD "90 tablets" vs. "1 tablet/week for adolescents" | Both involve iron-folate tablets | Adolescent (non-pregnant) girls receive 1 tablet per week year-round; pregnant women receive 1 tablet per day, minimum 90 tablets total |
LILA 23.5 cm threshold for KEK | Confused with BMI cutoffs | LILA is used as a rapid field screening for chronic energy deficiency; BMI is used for overall nutritional status. LILA <23.5 cm = KEK is the high-yield number. |
"Who must perform the ANC visit?" | Students assume all visits are by midwives (bidan) | Minimum 2 visits must be with a physician (trimester 1 and trimester 3), including USG at both |
Triple elimination at K1 | Students may only recall HIV testing and forget syphilis or hepatitis B | All three (HIV + syphilis + HBsAg) are tested simultaneously as a single package at the first contact |
Td status "unknown" | Students assume partial protection | If immunization status cannot be verified (no KIA book, no records), the patient is treated as T1 and immunization restarts from the beginning |
OAT in pregnancy | Students may not know which anti-TB drugs are contraindicated | Amikacin, Streptomycin, and Ethionamide/Prothionamide are not recommended during pregnancy |
Mental health screening | Students overlook this as part of ANC | T10 explicitly includes mental health assessment, performed at minimum in trimester 1 and trimester 3 |
09High-Yield Pearls
The most common way students lose points on ANC questions is by applying outdated standards. The shift from K4 to K6 is a regulation-level change that exam writers use to separate current from outdated knowledge. If a vignette asks for the minimum number of antenatal visits per current national guidelines, the answer is 6, not 4.
Another frequent trap involves the physician visit requirement. Many students assume ANC is exclusively a midwife's domain. Under Permenkes 21/2021, at least 2 of the 6 visits must involve a doctor, with USG performed at both the trimester 1 and trimester 3 physician visits. The trimester 1 physician visit focuses on risk factor screening, while the trimester 3 physician visit focuses on birth planning and referral arrangement.
Students also commonly forget that T8 (laboratory testing) at the first visit is not optional. The triple elimination panel (HIV, syphilis, hepatitis B) is a mandatory national program integrated into ANC. A question that presents a pregnant woman at her first visit and asks "what laboratory tests should be ordered?" expects the student to list hemoglobin, blood type with Rh, and the triple elimination rapid tests as the baseline panel.
The LILA threshold of 23.5 cm for KEK is one of the most testable numbers in the entire ANC module. It frequently appears as a clinical detail in vignettes where the student must identify that the pregnant woman is at nutritional risk and counsel her accordingly.
Finally, the TTD dosing distinction between pregnant women (1 tablet/day, minimum 90 tablets) and non-pregnant adolescent girls (1 tablet/week, year-round) is a classic distractor pair. The exam expects you to match the correct dosing schedule to the correct population.